| Joshua Clark Campbell, MD | |
|
3580 Joseph Siewick Dr Ste 105, Fairfax, VA 22033-1764 | |
| (703) 970-6464 | |
| (703) 970-6565 |
| Full Name | Joshua Clark Campbell |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 12 Years |
| Location | 3580 Joseph Siewick Dr Ste 105, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437564150 | NPI | - | NPPES |
| D83628 | Other | MD | MARYLAND MEDICAL LICENSE |
| A130780 | Other | CA | CALIFORNIA MEDICAL LICENSE |
| MD047881 | Other | DC | DC MEDICAL LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Home Health Llc | Fairfax, VA | Home health agency |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.
Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.
› Verified 4 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.
Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.
› Verified 4 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20110104001122 |
News Archive
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.
Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Clark Campbell, MD Po Box 37174, Baltimore, MD 21297-3174 Ph: (571) 423-5699 | Joshua Clark Campbell, MD 3580 Joseph Siewick Dr Ste 105, Fairfax, VA 22033-1764 Ph: (703) 970-6464 |
News Archive
A metallic molecule being studied at Rice University begins to glow when bound to amyloid protein fibrils of the sort implicated in Alzheimer's disease. When triggered with ultraviolet light, the molecule glows much brighter, which enables real-time monitoring of amyloid fibrils as they aggregate in lab experiments.
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.
Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.
› Verified 4 days ago
Dr. Greg E Gaski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8501 Arlington Blvd Ste 200, Fairfax, VA 22031 Phone: 703-970-6464 Fax: 703-970-6465 | |
Robert B Stinger, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8501 Arlington Blvd Ste 200, Fairfax, VA 22031 Phone: 703-205-2626 Fax: 703-205-7324 | |
Dr. George Damon Gantsoudes, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3023 Hamaker Ct Ste 500, Fairfax, VA 22031 Phone: 703-876-2788 | |
Brent R Ain, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3650 Joseph Siewick Dr, Suite 300, Fairfax, VA 22033 Phone: 703-391-0111 Fax: 703-391-2945 | |
Sohail K Mirza, M.D., M.P.H. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4250 Chain Bridge Rd, Fairfax, VA 22030 Phone: 703-828-6579 Fax: 571-458-7336 | |
Meryl Rutkowski Ludwig, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3023 Hamaker Ct Ste 500, Fairfax, VA 22031 Phone: 703-876-2788 | |
Keith Willis Lawhorn, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3620 Joseph Siewick Dr, Suite 100, Fairfax, VA 22033 Phone: 703-810-5223 Fax: 703-810-5403 |